Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: USPTO Page 26 to be considered

<In any case, I don't see where the USPTO action on the '584 has ANYTHING to do with the Js inclination to SETTLE on the '148 and '336 >

That is what you said, but I do not believe that is what you meant. If you have been reading the thread, why do you come to that conclusion? To me it seems perfectly logical that the Markman results for the 148/336 is going to help us as much as the Markman results for tje 584 hurt us. Optli

Share
New Message
Please login to post a reply